跳至主要内容
临床试验/NCT02964026
NCT02964026已完成不适用

Retrospective Analysis of Clinical Outcomes Associated With Use of the Pulmonary Artery Catheter (PAC) in Cardiac Surgery Patients Within the Cerner HealthFacts Database

Vanderbilt University0 个研究点目标入组 6,844 人开始时间: 2016年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
6,844
主要终点
Hospital mortality during index visit

研究概览

简要总结

The primary objective for this retrospective Electronic Health Record (EHR) analysis is to evaluate the clinical outcomes associated with the utilization of a pulmonary artery catheter (PAC), for monitoring purposes, within patients undergoing cardiac surgeries (isolated coronary artery bypass graft [CABG], valve, aortic surgery, multi-procedures, other complex nonvalvular procedures and heart transplants). The study will be conducted using prospectively collected hospital inpatient data over a duration of over 5 years (Jan. 1, 2010 - June 30, 2015) using a large US electronic health database (Cerner HealthFacts; Kansas City, MO).

详细描述

A retrospective study will be conducted using prospectively collected hospital inpatient data over a duration of over 5 years (Jan. 1, 2010 - June 30, 2015) using a large US electronic health database (Cerner HealthFacts; Kansas City, MO). Patients who underwent a qualifying cardiac surgery (verified through use of selected valid International Classification of Diseases-9 procedure codes and/or Current Procedural Terminology [CPT] codes) will be included. Each patient's cohort designation will be defined based upon whether he/she did or did not receive a pulmonary artery catheter (PAC) for monitoring purposes. Propensity scores, which take into account patient and hospital demographics, patient comorbidities, surgical type (isolated coronary artery bypass graft [CABG], valve, aortic surgery, multi-procedures, other complex nonvalvular procedures and heart transplants), and pre-operative condition (via an adapted EuroSCORE II) will be utilized to "match" patients who received a PAC for monitoring purposes with those who did not, to form a matched study cohort. Clinical outcomes will be monitored through index visit discharge and up to 90 days post index visit discharge.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient undergoes a qualifying cardiac surgery between Jan 1, 2010 and January 1,
  • If multiple qualifying surgeries are present, the first in database will be utilized
  • Inpatient with a LOS of at least 48 hours
  • Treated arm receives a PAC for monitoring purposes within admission date and qualifying cardiac surgical day plus one via specified ICD-9 or CPT-4 codes, or EHR recorded PAC readings

排除标准

  • Cardiac surgery patients with age <18 years on index procedure date
  • Non-treated arm derived from an institution which does not have database documented use of ICD-9 or CPT-4 PAC placement codes for monitoring purposes [Lessens the likelihood that the untreated arm is indeed treated by ensuring that the patient would likely be coded if he/she had a PAC in place for monitoring purposes]
  • Patient record must have the demographics populated of age, gender, and race. ICD-9 diagnosis and procedure codes must be present in record for index visit, as well as medications administered over index visit
  • Patient must be treated at a hospital which performs a minimum of 100 qualifying cardiac procedures per year

结局指标

主要结局

Hospital mortality during index visit

时间窗: Admission through up to 180 days (hospital discharge)

Major Adverse Cardiac Events (MACE)

时间窗: Through 90 days

Hospital length-of-stay (LOS)

时间窗: Admission through up to 180 days (hospital discharge)

Index hospital visit LOS

Hospital readmission

时间窗: Through 90 days

Rate of hospital readmissions

Major morbidity composite

时间窗: Through 90 days

次要结局

  • New organ failure (cardiovascular, respiratory, coagulation, liver systems, renal)(Day 1 to discharge (up to 180 days))
  • Requirement for mechanical ventilation(Day 1 to discharge (up to 180 days))
  • Acute kidney injury (KDIGO staging)(Day 1 to day 10)
  • Gastrointestinal complication (hepatic)(Day 1 to discharge (up to 180 days))
  • Respiratory failure(Day 1 to discharge (up to 180 days))
  • Sequential Organ Failure Assessment (SOFA) scores(Day 1 to discharge (up to 180 days))
  • Neurologic complication(Day 1 to discharge (up to 180 days))
  • Hemorrhage requiring blood transfusion(Day 1 to discharge (up to 180 days))
  • Infectious complications(Day 1 to discharge (up to 180 days))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrew Shaw

Professor and Executive Vice Chair Department of Anesthesiology Executive Medical Director, Perioperative Services

Vanderbilt University

相似试验